RECOMBINANT EXPRESSION VECTORS FOR ENCAPSULIN-BASED VACCINE PRODUCTION AND METHODS FOR THEM.

VN10060840BActive Publication Date: 2026-09-03INTHERA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
VN1202208658
Authority / Receiving Office
VN · VN
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-05-31
Publication Date
2026-09-03
Estimated Expiration
2041-05-31
Patent Text Reader

Abstract

The invention relates to an encapsulin protein and a fusion protein comprising this protein, and specifically to a recombinant expression vector for vaccine production, and a method for producing a vector strain containing the polynucleotide encoding the target protein, the encapsulin protein, and the interaction domain RNA (RLD) protein, to improve the expression efficiency of the target protein, and thus enable the production of a highly effective water-soluble vaccine using a large amount of the target protein. Furthermore, the invention relates to a method for producing this vaccine.
Need to check novelty before this filing date? Find Prior Art